Literature DB >> 11096491

Arrhythmogenic Right Ventricular Dysplasia.

.   

Abstract

Despite recurrences of ventricular tachycardia, patients with arrhythmogenic right ventricular dysplasia have a favorable prognosis with medical therapy. Because of the low incidence of arrhythmic death and the problems involved in identifying patients at high risk, it is difficult to evaluate the benefits of interventional therapies (ablation, surgery, and implantable cardioverter-defibrillators).

Entities:  

Year:  1999        PMID： 11096491     DOI： 10.1007/s11936-999-0042-4

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  23 in total

1.  Guidelines for Clinical Intracardiac Electrophysiological and Catheter Ablation Procedures. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures). Developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

2.  Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging.

Authors:  M D Carlson; R D White; R G Trohman; L P Adler; L A Biblo; K A Merkatz; A L Waldo
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

Review 3.  Adenosine-sensitive ventricular tachycardia: a conceptual approach.

Authors:  B B Lerman; K M Stein; S M Markowitz
Journal:  J Cardiovasc Electrophysiol       Date:  1996-06

4.  Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.

Authors:  T Wichter; M Borggrefe; W Haverkamp; X Chen; G Breithardt
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

5.  Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging.

Authors:  S M Markowitz; B L Litvak; E A Ramirez de Arellano; J A Markisz; K M Stein; B B Lerman
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

6.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.

Authors:  Q Chen; G E Kirsch; D Zhang; R Brugada; J Brugada; P Brugada; D Potenza; A Moya; M Borggrefe; G Breithardt; R Ortiz-Lopez; Z Wang; C Antzelevitch; R E O'Brien; E Schulze-Bahr; M T Keating; J A Towbin; Q Wang
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

7.  Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.

Authors:  M Borggrefe; H J Trampisch; G Breithardt
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

8.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

9.  Radiofrequency catheter ablation for management of symptomatic ventricular ectopic activity.

Authors:  D W Zhu; J D Maloney; T W Simmons; J Nitta; D M Fitzgerald; R G Trohman; D S Khoury; W Saliba; K M Belco; C Rizo-Patron
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

10.  Recurrent ventricular tachycardia responsive to verapamil.

Authors:  G J Klein; P J Millman; R Yee
Journal:  Pacing Clin Electrophysiol       Date:  1984-11       Impact factor: 1.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.